Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Journal of Molecular Medicine (Berlin, Germany)|May 29, 2010
Identification of p27/KIP1 expression level as a candidate biomarker of response to rapalogs therapy in human cancerGuang Chen, Na Yang, Xiang Wang, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 5, 2010
WJD008, a dual phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin inhibitor, prevents PI3K signaling and inhibits the proliferation of transformed cells with oncogenic PI3K mutantTing Li, Jia Wang, Xiang Wang, et al.
Breast Cancer Research and Treatment|December 25, 2010
PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivoJin-gui Ma, He Huang, Si-meng Chen, et al.
Journal of Medicinal Chemistry|March 24, 2017
6-OH-Phenanthroquinolizidine Alkaloid and Its Derivatives Exert Potent Anticancer Activity by Delaying S Phase ProgressionYuxiu Liu, Lihua Qing, Chuisong Meng, et al.
International Journal of Cancer|April 8, 2014
HSP90 inhibitor AUY922 abrogates up-regulation of RTKs by mTOR inhibitor AZD8055 and potentiates its antiproliferative activity in human breast cancerSi-Meng Chen, Chen-Liang Guo, Jia-Jie Shi, et al.
Theranostics|April 7, 2017
Integration of Receptor Tyrosine Kinases Determines Sensitivity to PI3Kα-selective Inhibitors in Breast CancerYi-Chao Xu, Xiang Wang, Yi Chen, et al.
Acta Pharmacologica Sinica|May 19, 2025
JMC14: a novel dual PI3Kδ/CSF1R inhibitor with potent antitumor activity in hematological and solid tumorsXi Zhang, Pu Sun, Yi Wang, et al.
International Journal of Cancer|January 24, 2019
Membrane metallo-endopeptidase mediates cellular senescence induced by oncogenic PIK3CA<sup>H1047R</sup> accompanied with pro-tumorigenic secretomeXue-Ling Liu, Jia-Li Liu, Yi-Chao Xu, et al.
International Journal of Biological Sciences|February 13, 2023
Xanthine dehydrogenase rewires metabolism and the survival of nutrient deprived lung adenocarcinoma cells by facilitating UPR and autophagic degradationMan-Man Chen, Wei Guo, Si-Meng Chen, et al.
Oncotarget|October 15, 2014
Simultaneous targeting of PI3Kδ and a PI3Kδ-dependent MEK1/2-Erk1/2 pathway for therapy in pediatric B-cell acute lymphoblastic leukemiaXiang Wang, Xi Zhang, Ben-shang Li, et al.
Pageof 7